Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine Networks Reprogramming the Osteo-Immune Microenvironment in Cancer Bone Metastasis.

Calcified tissue international·2026
Same author

Prognostic impact of rheumatoid arthritis on respiratory-related mortality in non-tuberculous mycobacterial pulmonary disease.

RMD open·2026
Same author

Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis.

International immunology·2026
Same author

Gastric Aspirate Isolate Demonstrates Strain-Level Concordance With Sputum Isolate in Nontuberculous Mycobacterial Pulmonary Disease.

Open forum infectious diseases·2026
Same author

Comparison of culture and culture-free methods for comprehensive identification of mycobacteria: a single-center prospective study.

Journal of clinical microbiology·2026
Same author

Corrigendum to 'Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan' [Annals of Allergy, Asthma & Immunology, Volume 130, Issue 5 (2023) 607-616.e3].

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Related Experiment Video

Updated: May 10, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Differences in physiological response to exercise in patients with different COPD severity.

Ryoji Maekura1, Toru Hiraga, Keisuke Miki

  • 1Department of Respiratory Medicine, National Hospital Organization Toneyama Hospital, Toyonaka City, Osaka, Japan.

Respiratory Care
|July 4, 2013
PubMed
Summary

Patients with COPD experience reduced exercise tolerance due to factors like hypoxemia and acidosis. Those with the lowest exercise capacity show exercise-induced hypoxemia, sympathetic overactivity, and respiratory acidosis during low-intensity exercise.

Keywords:
COPDacidosiscardiopulmonary exercise testinghypoxemiapeak oxygen uptakesympathetic overactivity

More Related Videos

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 10, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Area of Science:

  • Pulmonary Medicine
  • Cardiorespiratory Physiology
  • Exercise Science

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) significantly impairs exercise tolerance, often linked to dyspnea.
  • Key contributing factors include compromised ventilatory mechanics, inefficient gas exchange, early lactic acidosis, and exercise-induced hypoxemia.
  • Understanding the exercise pathophysiology in COPD patients with severely limited exercise capacity is crucial for prognosis.

Purpose of the Study:

  • To characterize life-threatening factors during exercise in COPD patients.
  • Specifically aimed to investigate hypoxemia, acidosis, and sympathetic activation in relation to exercise capacity.

Main Methods:

  • Ninety-one COPD subjects underwent incremental cardiopulmonary exercise testing.
  • Changes in arterial blood gases, lactate, and catecholamines were monitored.
  • Subjects were stratified into quartile groups based on peak oxygen uptake.

Main Results:

  • Significant differences in exercise pathophysiology were observed across exercise capacity groups.
  • Severely limited exercisers (peak oxygen uptake ≤ 623 mL/min) exhibited pronounced exercise-induced hypoxemia, rapid respiratory acidosis, and sympathetic activation at low workloads.
  • These findings were coupled with limited ventilatory increases and impaired gas exchange.

Conclusions:

  • Exercise intolerance mechanisms vary considerably among COPD patients with different exercise capacities.
  • The most exercise-limited group demonstrated exercise-induced hypoxemia, sympathetic overactivity, and progressive respiratory acidosis during low-intensity exercise.
  • These critical conditions may be amenable to interventions like medication and pulmonary rehabilitation.